Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib

BACKGROUND: There has been a recent surge in interest in predicting biological effects associated with genomic alterations in order to implement personalized cancer treatment strategies. However, no reports have yet evaluated the utility of profiling blood-based circulating tumor DNA (ctDNA) in hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Yasutoshi, Ono, Atsushi, Hayes, C. Nelson, Aikata, Hiroshi, Yamauchi, Masami, Uchikawa, Shinsuke, Kodama, Kenichiro, Teraoka, Yuji, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Miki, Daiki, Okamoto, Wataru, Kawaoka, Tomokazu, Tsuge, Masataka, Imamura, Michio, Chayama, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235843/
https://www.ncbi.nlm.nih.gov/pubmed/34174931
http://dx.doi.org/10.1186/s13046-021-02016-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235843/
https://www.ncbi.nlm.nih.gov/pubmed/34174931
http://dx.doi.org/10.1186/s13046-021-02016-3

Ejemplares similares